BioMarin Pharmaceutical (BMRN) total debt

Total debt · fiscal 2025
$605.86M

BioMarin Pharmaceutical (BMRN) carried total debt of $605.86M at the end of fiscal 2025 (December 31, 2025). That is 0.5% higher than the $602.71M of fiscal 2024. Figures as of 18 Nov 2026, 07:03 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$605.86M
Change on fiscal 2024
+0.5%
Highest on record
$1.10Bfiscal 2023
Lowest on record
$602.71Mfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

BioMarin Pharmaceutical total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $1.10B in fiscal 2023 and the lowest $602.71M in fiscal 2024.

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

BioMarin Pharmaceutical total debt, year by year

BioMarin Pharmaceutical (BMRN) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$605.86M 0.5% up0.1×
2024$602.71M 45.0% down0.1×
2023$1.10B 0.2% up0.2×
2022$1.09B—0.2×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of BioMarin Pharmaceutical and comparable companies
CompanyTotal debtFiscal year
Universal Health Services UHS$5.17B2025
Repligen RGEN$689.95M2025
Bio-Techne TECH$289.09M2026
BioMarin Pharmaceutical BMRN$605.86M2025
Avantor AVTR$3.95B2025
Ensign Group ENSG$2.21B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BMRN

BioMarin Pharmaceutical, figure by figure

BioMarin Pharmaceutical (BMRN) overview: price, valuation and scorecardAll health care companies by market value

BioMarin Pharmaceutical total debt: questions and answers

How much debt does BioMarin Pharmaceutical have?

BioMarin Pharmaceutical (BMRN) carried total debt of $605.86M at the end of fiscal 2025 (December 31, 2025). That is 0.5% higher than the $602.71M of fiscal 2024.

What are the highest and lowest total debt figures on record for BioMarin Pharmaceutical?

Across the 4 fiscal years on record (2022–2025), the highest was $1.10B in fiscal 2023 and the lowest $602.71M in fiscal 2024.

How does BioMarin Pharmaceutical's debt compare with its equity?

Total debt was 0.1× shareholders' equity at the end of fiscal 2025.

How is BioMarin Pharmaceutical's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BioMarin Pharmaceutical (BMRN) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/BMRN/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.